Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

817
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
817
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

48
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
48
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.3K
Hormonal Regulation01:33

Hormonal Regulation

33.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.7K
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

1.8K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.8K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Increasing the number of surgically cured primary aldosteronism patients: The promise of simplified diagnosis and advanced nuclear adrenocortical imaging.

American journal of surgery·2023
Same author

Automated Item Generation: impact of item variants on performance and standard setting.

BMC medical education·2023
Same author

Early Dalmatian farmers specialized in sheep husbandry.

Scientific reports·2023
Same author

Novel imaging techniques in refractory pituitary adenomas.

Pituitary·2023
Same author

Secondary amenorrhoea with absent axillary hair.

European journal of internal medicine·2023
Same author

The influence of candidates' physical attributes on patient ratings in simulated assessments of clinical practice.

Medical teacher·2022
Same journal

ADAM17 as a promising molecular target for organ protection in antihypertensive therapy.

American journal of hypertension·2026
Same journal

Efficacy and Safety of Baxdrostat in the Management of Uncontrolled Hypertension: A Systematic Review and Meta-Analysis.

American journal of hypertension·2026
Same journal

Hemodynamic Evolution of Heart Failure from Hypertension: Lower Stroke Volume Index and Higher Heart Rate.

American journal of hypertension·2026
Same journal

Opposite Seasonal Variation in Nighttime and Morning Blood Pressure: A Longitudinal Study of Patients with Hypertension.

American journal of hypertension·2026
Same journal

Screening for Postprandial Hypotension: The Importance of Home Blood Pressure Monitoring.

American journal of hypertension·2026
Same journal

Distinct Mediating Roles of Hypertension in Arterial Stiffness Mechanisms Associated with Cardiovascular Disease Risk: A Community-Based Cohort Study.

American journal of hypertension·2026
関連記事をすべて見る

関連する実験動画

Updated: Sep 9, 2025

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

23.6K

初期アルドステロン症の 確認検査を中止すべきか?

G A Kline1, A A Leung1, D Orton2

  • 1Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada.

American journal of hypertension
|September 1, 2025
PubMed
まとめ
この要約は機械生成です。

アルドステロン抑制検査を用いた原発性アルドステロン症 (PA) の診断は,生化学スペクトル,測定の可変性,および多因体の病理生理学により信頼できない. 現在の証拠は PA診断の伝統的な検査を廃止することを示唆しています

キーワード:
高血圧アルドステロン主要アルドステロン症二次高血圧

さらに関連する動画

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions
04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

8.2K
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

3.7K

関連する実験動画

Last Updated: Sep 9, 2025

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

23.6K
Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions
04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

8.2K
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

3.7K

科学分野:

  • 内分泌学
  • 高血圧 研究
  • 診断医学

背景:

  • 主要アルドステロン症 (PA) は内分泌高血圧の最も一般的な原因です.
  • 診断は伝統的にレニン-アニオテンシン-アルドステロン経路を評価するアルドステロン抑制試験に依存しています.
  • これらの検査は 初期の病理学的な研究に基づいて 何十年も標準的に行われてきました

研究 の 目的:

  • 伝統的なアルドステロン抑制検査の診断的有用性を批判的に評価する.
  • これらのテストの妥当性や信頼性を疑う現代的な証拠を強調する.
  • PAの診断戦略の再評価を提案する.

主な方法:

  • PAの病理生理学の現代的な理解のレビュー.
  • メタ分析を含む診断試験の批判的評価
  • 塩水抑制試験に関する最近の前向きな盲検試験の分析

主要な成果:

  • 抑制試験は,連続した生化学スペクトル,アルドステロン測定の不確実性,多因子PA病理学,および研究バイアスなどの課題に直面しています.
  • 最近の研究では 塩素抑制検査は 診断上の差別性を欠いていることが示されました
  • メタ解析はバイアスや混同因子による診断値の過大評価を示している.

結論:

  • 伝統的なアルドステロン抑制検査は,PAの診断や疾患の定義に科学的に不適しています.
  • PAの連続的な性質と測定制限は,単一の診断基準を無効にします.
  • 抑制検査を廃止し,PAの新たな診断方法を探求することを支持する証拠があります.